Skip to main content

Table 1 Baseline characteristics of study participants and medications

From: Low-volume high-intensity interval training improves cardiometabolic health, work ability and well-being in severely obese individuals: a randomized-controlled trial sub-study

  HIIT (n = 36) CON (n = 29)
Variable
 Men/women (n) 19/17 10/19
 Age (years) 48.5 ± 10.0 49.0 ± 9.9
 Body mass index (kg/m2) 40.4 ± 7.2 38.5 ± 6.9
 VO2max (mL/kg/min) 21.9 ± 6.2 21.7 ± 7.1
Medications, n (%)
 Beta blockers 2 (5.6%) 3 (10.3%)
 ACE inhibitors 10 (27.8%) 8 (27.6%)
 Non ACE inhibitors 7 (19.4%) 4 (13.8%)
 Metformin 5 (13.9%) 3 (10.3%)
 Exogenous insulin 1 (2.8%) 0
 Anticoagulants 1 (2.8%) 0
 Bronchodilators 1 (2.8%) 1 (3.4%)
 Antihistamines 0 3 (10.3%)
 l-thyroxine 4 (11.1%) 8 (27.6%)
 Analgesics 8 (22.2%) 9 (31.0%)
 Anti-depressants 5 (13.9%) 4 (13.8%)
  1. HIIT High-intensity interval training group, CON control group